Smoking duration, intensity, and risk of Parkinson disease
- PMID: 20220126
- PMCID: PMC2836869
- DOI: 10.1212/WNL.0b013e3181d55f38
Smoking duration, intensity, and risk of Parkinson disease
Abstract
Objective: To evaluate the relative importance of smoking duration vs intensity in reducing the risk of Parkinson disease (PD).
Methods: The study included 305,468 participants of the NIH-AARP Diet and Health cohort, of whom 1,662 had a PD diagnosis after 1995. We estimated odds ratios (OR) and 95% confidence intervals from multivariate logistic regression models.
Results: Compared with never smokers, the multivariate ORs were 0.78 for past smokers and 0.56 for current smokers. Among past smokers, a monotonic trend toward lower PD risk was observed for all indicators of more smoking. Stratified analyses indicated that smoking duration was associated with lower PD risk within fixed intensities of smoking. For example, compared with never smokers, the ORs among past smokers who smoked >20 cigarettes/day were 0.96 for 1-9 years of smoking, 0.78 for 10-19 years, 0.64 for 20-29 years, and 0.59 for 30 years or more (p for trend = 0.001). In contrast, at fixed duration, the typical number of cigarettes smoked per day in general was not related to PD risk. Close examination of smoking behaviors in early life showed that patients with PD were less likely to be smokers at each age period, but if they smoked, they smoked similar numbers of cigarettes per day as individuals without PD.
Conclusions: This large study suggests that long-term smoking is more important than smoking intensity in the smoking-Parkinson disease relationship.
Figures

Comment in
-
After half a century of research on smoking and PD, where do we go now?Neurology. 2010 Mar 16;74(11):870-1. doi: 10.1212/WNL.0b013e3181d63aa8. Epub 2010 Mar 10. Neurology. 2010. PMID: 20220125 No abstract available.
-
Smoking duration, intensity, and risk of Parkinson disease.Neurology. 2010 Aug 10;75(6):574-5; author reply 574. doi: 10.1212/WNL.0b013e3181ec67f1. Neurology. 2010. PMID: 20697113 No abstract available.
References
-
- Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002;52:276–284. - PubMed
-
- Tanner CM, Goldman SM, Aston DA, et al. Smoking and Parkinson's disease in twins. Neurology 2002;58:581–588. - PubMed
-
- Mellick GD, Gartner CE, Silburn PA, Battistutta D. Passive smoking and Parkinson disease. Neurology 2006;67:179–180. - PubMed
-
- Quik M, O'Neill M, Perez XA. Nicotine neuroprotection against nigrostriatal damage: importance of the animal model. Trends Pharmacol Sci 2007;28:229–235. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources